Vulval cancer

Cancer of the vulva is a rare type of cancer that affects women.

The vulva is a woman's external genitals. It includes:

Most of those affected by vulval cancer are older women over the age of 65.

The condition is rare in women under 50 who have not yet gone through the menopause.

Symptoms of vulval cancer

Symptoms of vulval cancer can include:

See a GP if you notice any changes in the usual appearance of your vulva.

While it's highly unlikely to be the result of cancer, these changes should be investigated.

What causes vulval cancer?

The exact cause of vulval cancer is unclear, but your risk of developing the condition is increased by the following factors:

You may be able to reduce your risk of vulval cancer by stopping smoking and taking steps to reduce the chances of picking up an HPV infection.

How vulval cancer is treated

The main treatment for vulval cancer is surgery to remove the cancerous tissue from the vulva and any lymph nodes containing cancerous cells.

Some people may also have radiotherapy, where radiation is used to destroy cancer cells, or chemotherapy, where medicine is used to kill cancer cells, or both.

Radiotherapy and chemotherapy may be used without surgery if you're not well enough to have an operation, or if the cancer has spread and it's not possible to remove it all.


The outlook for vulval cancer depends on things such as how far the cancer has spread, your age, and your general health.

Generally, the earlier the cancer is detected and the younger you are, the better the chances of treatment being successful.

Overall, around 7 in every 10 women diagnosed with vulval cancer will survive at least 5 years.

But even after successful treatment, the cancer can come back.

You'll need regular follow-up appointments so your doctor can check if this is happening.

Can vulval cancer be prevented?

It's not thought to be possible to prevent vulval cancer completely, but you may be able to reduce your risk by:

The HPV vaccination may also reduce your chances of developing vulval cancer.

This is now offered to all girls and boys who are 12 to 13 years old as part of the routine childhood immunisation programme.

Page last reviewed: 30 April 2021
Next review due: 30 April 2024